| Literature DB >> 12486002 |
Vanessa Brès1, Hideaki Tagami, Jean-Marie Péloponèse, Erwan Loret, Kuan-Teh Jeang, Yoshihiro Nakatani, Stephane Emiliani, Monsef Benkirane, Rosemary E Kiernan.
Abstract
The HIV-1 transactivator protein, Tat, is an atypical transcriptional activator that functions through binding, not to DNA, but to a short leader RNA, TAR. Although details of its functional mechanism are still unknown, emerging findings suggest that Tat serves primarily to adapt co-activator complexes such as p300, PCAF and P-TEFb to the HIV-1 long terminal repeat. Hence, an understanding of how Tat interacts with these cofactors is crucial. It has recently been shown that acetylation at a single lysine, residue 50, regulated the association of Tat with PCAF. Here, we report that in the absence of Tat acetylation, PCAF binds to amino acids 20-40 within Tat. Interestingly, acetylation of Tat at Lys28 abrogates Tat-PCAF interaction. Acetylation at Lys50 creates a new site for binding to PCAF and dictates the formation of a ternary complex of Tat-PCAF-P-TEFb. Thus, differential lysine acetylation of Tat coordinates the interactions with its co-activators, cyclin T1 and PCAF. Our results may help in understanding the ordered recruitment of Tat co-activators to the HIV-1 promoter.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12486002 PMCID: PMC139090 DOI: 10.1093/emboj/cdf669
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598